Dave Muoio
Pharma giant Roche is set to acquire oncology EHR software firm Flatiron Health in the first half of 2018, the companies announced today in a statement.
Insulin dose tool gains CE Mark.
As new technologies and consumer-focused strategies continue their takeover of the healthcare industry, health systems will have to adjust their care models or be left in the dust.
The FDA announced yesterday that it will permit marketing of Viz.
Digital diabetes care company Glooko announced today that its Mobile Insulin Dosing System (MIDS) — an app-driven tool that recommends insulin dose adjustments using data collected directly from a patient’s blood glucose meter — has been cleared by the FDA.
Clarify Medical will be debuting its handheld, smartphone-connected phototherapy device later this week at the American Academy of Dermatology Annual Meeting, according to a statement.
Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence.
Data from a recent analysis suggest that a substantial number of popular health apps have major privacy and security shortcomings, with many not following standard practices and upcoming European Union data safety regulations.
HealthifyMe, an Indian company offering a weight loss and fitness app that features an artificial intelligence-powered assistant, has raised $12 million in Series B funding.
Hurried conversations, paper brochures, and other long-standing approaches to patient education often fall short of their goals, so it’s little surprise that researchers are eyeing digital technologies as a potential solution.